Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer.
出版信息
Front Oncol. 2024 Feb 21;14:1383383. doi: 10.3389/fonc.2024.1383383. eCollection 2024.
Abstract
[This retracts the article DOI: 10.3389/fonc.2023.1132186.].
摘要
相似文献
1
Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer.
Front Oncol. 2024 Feb 21;14:1383383. doi: 10.3389/fonc.2024.1383383. eCollection 2024.
2
Magnetic resonance examination to predict pathological complete response following neoadjuvant chemotherapy: when is it appropriate for HER2-positive and triple-negative breast cancers?磁共振检查预测新辅助化疗后的病理完全缓解：HER2阳性和三阴性乳腺癌何时适用？
Breast Cancer. 2016 Sep;23(5):789-96. doi: 10.1007/s12282-015-0642-7. Epub 2015 Oct 5.
3
Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.术前磁共振成像的乳腺癌计算机纹理分析特征与新辅助化疗的反应相关。
Radiology. 2018 Feb;286(2):412-420. doi: 10.1148/radiol.2017170143. Epub 2017 Oct 4.
4
Analysis of the relevance between molecular subtypes and efficacy of neoadjuvant chemotherapy in breast cancer as well as its prognostic factors.乳腺癌新辅助化疗分子亚型与疗效的相关性及其预后因素分析
Pathol Res Pract. 2018 Aug;214(8):1166-1172. doi: 10.1016/j.prp.2018.06.010. Epub 2018 Jun 19.
5
Application of triple evaluation method in predicting the efficacy of neoadjuvant therapy for breast cancer.三重评估方法在预测乳腺癌新辅助治疗疗效中的应用。
World J Surg Oncol. 2023 Mar 29;21(1):116. doi: 10.1186/s12957-023-02998-8.
6
7
Prediction of pathological response to neoadjuvant chemotherapy in breast cancer patients by imaging.通过影像学预测乳腺癌患者对新辅助化疗的病理反应
J Surg Res. 2018 May;225:175-180. doi: 10.1016/j.jss.2017.12.002. Epub 2018 Feb 21.
8
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.新辅助多西他赛和阿霉素化疗治疗Ⅱ/Ⅲ期乳腺癌时临床病理参数的预后影响：三阴性乳腺癌的矛盾特征
BMC Cancer. 2007 Nov 1;7:203. doi: 10.1186/1471-2407-7-203.
9
Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival.监测三阴性乳腺癌新辅助化疗患者的血清 VEGF：一种早期预测治疗反应和患者生存的新策略。
Oncologist. 2019 Jun;24(6):753-761. doi: 10.1634/theoncologist.2017-0602. Epub 2018 Aug 20.
10
Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.使用扩散加权成像和动态对比增强磁共振成像评估乳腺癌新辅助化疗的疗效。
Neoplasma. 2017;64(3):430-436. doi: 10.4149/neo_2017_314.
Zotero 插件